Welcome
to the updated Immunization Page!
In
an effort to consolidate and organize the rapidly changing
information on vaccinations for children, this page has been
re-organized to make it easier to navigate. The main areas
may be reached by using the links on the left. Important new
links will be listed below.
AAP
District II is consolidating vaccine information so that it is not
duplicated on the Chapter web sites. If you have arrived here by
using a link from a New York Chapter web site, you may return by
clicking here or on the links to the left.
If
you would like to follow current pending legislation regarding
immunizations, click on this
link, then click on the New York area.
The
NYS Department of Health Immunization Program has recently
developed the above document which outlines the guidelines for
immunizing women before, during and after pregnancy. It was
developed based on current recommendations from the Centers for
Disease Control and Prevention, the Advisory Committee on
Immunization Practices and the American College of Obstetricians
and Gynecologists.
In the single pdf file, you will find the following:
An
introductory letter
Guidelines
document
A
1-page CDC reference chart entitled "Immunization &
Pregnancy"
Frequently
Asked Questions about New York State Public Health Law §2112
Our
overarching message is: "NYSIIS implementation continues with
a focus on training, data submission and user support – NOT
compliance and enforcement.”Dr. Henry Schaeffer wants all pediatricians in New York to know that
"penalties for non-compliance will not be
issued during the implementation period, which should take a couple
of years."
Investigate
specs for data upload process. This link is to a pdf
file with the specifications
for you to give to you office management program
manufacturers.
Register
for formal training (when available) or complete independently
Begin
actively reporting within 30 days of training.
The NYSIIS
team is pleased to announce that development of the NYSIIS Online
Self-Guided Training Tutorials is now complete! The NYSIIS
tutorials were designed as a complement to both the classroom and
webinar training methods. These tutorials offer training
participants more training flexibility and an opportunity to
review specific functions and concepts as needed. There are
10 self-paced tutorials that demonstrate the core functions for
utilizing NYSIIS.
Based
on the recommendation of the Commissioner of Health, the
(Insurance) Department has determined that covered
necessary immunizations under the law are those recommended
by the ACIP, and should the ACIP amend its recommendations,
...HMOs will take the necessary steps to provide coverage in
accordance with the ACIP revised schedule, effective as of the
date of the change.
Please direct any questions concerning
the Circular Letter to:
Deborah A. Kozemko, J.D.
Supervising Insurance Attorney
New York State Insurance Department
One Commerce Plaza
Albany, NY 12257
E-mail: dkozemko@ins.state.ny.us
CDC Reinstates Hib Booster
Dose Due to Improving Supply (posted
6/27/2009)
Due to an improving supply of Haemophilus influenzae type b
(Hib) vaccine, the Centers for Disease Control and Prevention (CDC),
in consultation with the American Academy of Pediatrics and the
American Academy of Family Physicians, reinstated the booster dose
of Hib vaccine for all children 12 through 15 months of age on
June 25th.
Recommendations for reinstatement of Hib
booster dose
Infants should receive their primary Hib series at
ages 2, 4 and 6 months, and a Hib booster dose on time
at 12 through 15 months of age.
Older children for whom a Hib booster dose was
deferred should receive the Hib booster at the next
routinely scheduled visit or medical encounter.
Mass recall of children for their catch-up Hib booster
dose is not recommended at this time because physicians
may encounter supply problems during such a massive
recall.
"Updated Recommendations for Use of Haemophilus
influenzae Type b (Hib) Vaccine: Reinstatement of the
Booster Dose at Ages 12-15 Months," MMWR, June 26.
Although Merck has not yet returned to market with its Hib-containing
vaccines, sanofi pasteur has increased production of monovalent
Hib vaccine, PRP-T (ActHIB), and DTaP-IPV/Hib (Pentacel). Enough
Hib-containing vaccine is now available for distribution to allow
a return to the full dose schedule for all children 12 through 15
months of age and for children 15 through 60 months who come in
for routine health services and who did not receive their booster
dose. Providers should expect some additional doses of Hib vaccine
each month. However, supplies are not yet adequate to support a
mass recall of children whose booster dose was delayed.
For more information, see the article
in the July 2009 issue of AAP News, in addition to the Morbidity
and Mortality Weekly Report (MMWR) dispatch. The MMWR
dispatch includes additional recommendations to ensure that
eligible patients receive all currently recommended doses of this
important immunization.
Merck
PedvaxHIB Shortage
Merck has been working
diligently to restore market availability of their HIB-containing
vaccines, PedvaxHIB® and Comvax®. The goal was to return these
vaccines to market in the fourth quarter of 2008; however, they
recently identified the need for an additional manufacturing
change that will require a regulatory filing. Based on this
situation, Merck is revising their projected market return to
mid-2009 in the U.S. Merck is working hard to restore these
vaccines to full availability. CDC
will provide updates as more information becomes available
from Merck.
Please consult the
Catch-Up Immunization Schedule (found on page 3 of the schedule)
for the timing of doses for those who start late or are more than
one month behind: http://www.cdc.gov/vaccines/recs/schedules/
For
more information regarding recommendations during the recent Hib
shortage, please refer to the following (posted
6/3/2009):
